Severe decrease in serum HDL-cholesterol during combination therapy of bezafibrate and pioglitazone

被引:10
作者
Senba, Hiroaki [1 ]
Kawano, Mikihiko [1 ]
Kawakami, Masanobu [1 ]
机构
[1] Jichi Med Univ, Omiya Med Ctr, Dept Comprehens Med, Saitama, Japan
关键词
D O I
10.5551/jat.13.263
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
[No abstract available]
引用
收藏
页码:263 / 264
页数:2
相关论文
共 4 条
[1]  
Ebcioglu Zeynep, 2003, Ann Intern Med, V139, pW80
[2]   Severe hypo-α-lipoproteinemia during treatment with rosiglitazone [J].
Sarker, A ;
Semple, RK ;
Dinneen, SF ;
O'Rahilly, S ;
Martin, SC .
DIABETES CARE, 2004, 27 (11) :2577-2580
[3]   The nuclear receptors peroxisome proliferator-activated receptor α and Rev-erbα mediate the species-specific regulation of apolipoprotein A-I expression by fibrates [J].
Vu-Dac, N ;
Chopin-Delannoy, S ;
Gervois, P ;
Bonnelye, E ;
Martin, G ;
Fruchart, JC ;
Laudet, V ;
Staels, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (40) :25713-25720
[4]  
VUDAC N, 1994, J BIOL CHEM, V269, P31012